Expression of the metalloproteases MMP-1, MMP-2, MMP-3, MMP-9, MMP-11, TIMP-1 and TIMP-2 in angiocentric midfacial lymphomas

World Journal of Surgical Oncology

Volumn 6, Issue , 2008, Pages

  Meneses García, Abelardo ^a   Betancourt, Alejandro Mohar ^a   Abarca, Jorge Herrera ^b   Montes, Adriana Becerril ^b   Roa, Lourdes Suarez ^a   Ruíz Godoy, Luz ^a  

^a INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; METALLOPROTEINASE; STROMELYSIN; STROMELYSIN 3; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CELL ULTRASTRUCTURE; CONTROLLED STUDY; ENZYME ACTIVITY; FACE CANCER; FEMALE; GENETIC CORRELATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOMA; MALE; NOSE CAVITY; PROTEIN EXPRESSION; TUMOR LOCALIZATION; COHORT ANALYSIS; GENE EXPRESSION REGULATION; GENETICS; HOSPITALIZATION; METABOLISM; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; NEEDLE BIOPSY; NK T CELL LYMPHOMA; NOSE TUMOR; PATHOLOGY; PROBABILITY; PROGNOSIS; RISK ASSESSMENT; SURVIVAL;

ADULT; AGED; BIOPSY, NEEDLE; COHORT STUDIES; COMBINED MODALITY THERAPY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, EXTRANODAL NK-T-CELL; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MIDDLE AGED; NOSE NEOPLASMS; PROBABILITY; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TUMOR MARKERS, BIOLOGICAL;

EID: 56349094800     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-6-114     Document Type: Article

References (33)

1. Jaffe ES Chan JKC Su I-J Frizzera G Mori S Feller AC Ho FCS Report of the workshop on nasal an related extranodal angiocentric T/natural killer cell lymphomas. Definitions, differential diagnosis, and epidemiology Am J Surg Pathol 1996, 20:103-111 10.1097/ 00000478-199601000-00012 8540601
2. Campo E Cardesa A Alos L Palacin A Cotarro J Traserra J Montserrat E Non-Hodgkin's lymphomas of the nasal cavity and paranasal sinuses, and immunohistochemical study Am J Clin Pathol 1991, 96:184-190 1862773
3. Gaulard P Henni T Marolleau JP Haioun C Henni Z Voisin MC Divine M Goossens M Farcet JP Reyes F Lethal midline granuloma (polymorphic reticulosis) and lymphomatoid granulomatosis: Evidence for monoclonal T-cell lymphoproliferative disorder Cancer 1988, 62:705-710 10.1002/ 1097-0142(19880815)62:4<705::AID-CNCR2820620410>3.0.CO;2-Z 3260812
4. Eichel BS Harrison EG Jr Devine KD Scanlon PW Brown HA Primary lymphoma of the nose including a relationship of lethal midline granuloma Am J Surg 1996, 112:597-605 10.1016/0002-9610(66)90328-X
5. Jaffe ES Pathologic and clinical spectrum of post-thymic T-cell malignancies Cancer Investigation 1984, 2:413-426 10.3109/ 07357908409040316 6093950
6. Nakamura S Suchi T Koshikawa T Kitoh K Koike K Komatsu H Iida S Kagami Y Ogura M Katoh E et al. Clinicopathologic study of CD 56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract Am J Surg Path 1995, 19:284-296 7532919
7. Aozasa K Ohsawa M Tajima K Sasaki R Maeda H Matsunaga T Friedmann I Nation-wide study of lethal midline granuloma in japan: Frequencies of Wegener's granulomatosis, polymorphic reticulosis, malignant lymphoma and other related conditions Int J Cancer 1989, 44:63-6 10.1002/ ijc.2910440112 2744899
8. Ho FCS Todd D Loke SL Ng RP Khoo RKK Features of malignant lymphomas in 294 Hong Kong Chinese patients, retrospective study covering an eight year period Int J Cancer 1984, 34:143-148 10.1002/ijc.2910340202 6381328
9. Arber DA Weiss LM Albujar PF Chen YY Jaffe ES Nasal lymphomas in Peru, high incidence of T-cell immunophenotype and Epstein-Barr virus infection Am J Surg Pathol 1993, 17:392-399 10.1097/ 00000478-199304000-00010 8388175
10. Navarro-Roman L Zarate Osorno A Meneses-Garcia A Kingma DW Jaffe ES High grade AIL and Epstein-Barr virus infection in 22 cases from Mexico Mod Pathol 1994, 7:117A
11. Gaal K Sun NCJ Hernandez AM Farber DA Sinonasal T/NK cell lymphomas in the United States Am J Surg Pathol 2000, 24:1511-1517 10.1097/ 00000478-200011000-00006 11075852
12. Ng SB Lai KW Murugaya S Lee KM Loong SL Fook-Chong S Tao M Sng I Nasaltype extranodal natural killer/Tcell lymphomas: A clinicopathologic and genotypic study of 42 cases in Singapore Mod Pathol 2004, 17:1097-1107 10.1038/modpathol.3800157 15195107
13. Khania F Yao Q-Y Niedobitek G Sihota S Rickinson AB Young LS Analysis of Epstein-Barr gene polymorphisms in normal donors and in virus-associated tumors from different geographic locations Blood 1996, 88:3491-3501 8896415:
14. Chan JK Sin VC Wong KF Ng CS Tsang WY Chan CH Cheung MM Lau WH Non-nasal lymphomas expressing the natural killer cell marker CD 56: A clinicopathologic study of 49 cases of an uncommon aggressive neoplasm Blood 1997, 89:4501-4513 9192774
15. Quintanilla-Martinez L Jaffe ES Aggressive NK cell lymphoma insights in to the spectrum of NK cell derived malignancies Histopathology 2000, 37:372-374 10.1046/j.1365-2559.2000.01029.x 11012745
16. Elenitoba-Johnnson KJJ Zarate-Osorno A Meneses A Krenaccs L Kingma DW Raffeld M Jaffe ES Cytotoxic granular protein expression, Epstein-Barr virus strain type, and latent membrane protein-1 oncogene deletions in nasal T-lymphocyte/natural killer cell lymphomas from Mexico Mod Pathol 1998, 11:754-761 9720504
17. Tiang Q Streuli M Saito H Schlossman SF Anderson P A polyadenylate binding protein localized to the granules of cytolytic induces DNA fragmentation in target cells Cell 1991, 67:629-639 10.1016/ 0092-8674(91)90536-8 1934064
18. Smyth MJ Trapane JAA Granzymes: Exogenous proteinases that induce target cell apoptosis Immunol Today 1995, 16:202-206 10.1016/ 0167-5699(95)80122-7 7734049
19. Egablad M Werb Z New functions for the matrix metalloproteinases in cancer progression Nature Reviews/Cancer 2002, 2:161-174
20. Kossakowska AE Edwards DR Prusinkiewicz C Zhang MC Guo D Urbanski SJ Grogan T Marquez LA Janowska-Wieczorek A Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TIMP-1) expression in malignant non-Hodgkin's lymphomas Blood 1999, 94:2080-2089 10477738
21. Stetler-Stevenson M Mansoor A Lim M Fukushima P Kehrl J Marti G Ptaszynski K Wang J Stetler-Stevenson WG Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in reactive and neoplastic lymphoid cells Blood 89:1708-1715 9057654
22. Franchi A Santucci M Masini E Sardi I Paglierani M Gallo O Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and metalloproteinase 9 in carcinoma of the head and neck. Correlation with p53 status, inductible nitric oxide synthase activity, and angiogenesis Cancer 2002, 95:1902-1910 10.1002/cncr.10916 12404284
23. Yamanaka N Nakamura A Minase T Sambe S Ishi Y Tcell lymphoma: characterization by monoclonal antibodies Ann Otol Rhinol Laryngol 1985, 94:207-211 3922275
24. Nava VE Jaffe ES The pathology of NK-cell lymphomas and leukemias Adv Anat Pathol 2005, 12:27-34 10.1097/01.pap.0000151318.34752.80 15614162
25. Ioachim EE Athanassiaadou SE Kamina S Carassavoglou K Agnantis NJ Matrix metalloproteinase expression in human breast cancer: An immunohistochemical study including correlation with cathepsin D, type IV, collagen, laminin, fibronectin, EFGR, c-erbB2 ocoprotein, p53, steroid receptors status and proliferative activity Anticancer Res 1998, 18:1665-1770 9673387
26. Kurahara S Shinohara M Ikebe T Nakamura S Beppu M Hiraki A Takeuchi H Shirasuna K Expression of MMPs, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: Correlations with tumor invasion and metastasis Head Neck 1999, 21:627-638 10.1002/ (SICI)1097-0347(199910)21:7<627::AID-HED7>3.0.CO;2-2 10487950
27. Harada T Shinohara M Nakamura S Oka M An immunohistochemical study of extracellular matrix in oral squamous cell carcinoma and its association with invasive and metastatic potential Virchows Arch 1994, 424(3):257-266 10.1007/BF00194609 7514477
28. Zeng ZC Cohen AM Zhang ZF Stetler-Stevenson W Guillem JG Elevated tissue inhibitor of metalloproteinase 1 RNA in colorectal cancer stroma correlates with lymph nodes and distant metastasis Clin Cancer Res 1995, 1:899-906 9816060
29. Yoshizaki T Sato H Furukawa M Pagano JS The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein1 Proc Natl Acad Sci USA 1998, 95:3621-3626 19885 9520415 10.1073/ pnas.95.7.3621
30. Murono S Yoshizaki T Sato H Takeshita H Furukawa M Pagano JS Aspirin inhibitors tumor cell invasiveness induced by Epstein-Barr virus latent membrane protein 1 through suppression of matrix metalloproteinase-9 expression Cancer Res 2000, 60:2555-2561 10811139
31. Aoudjit F Potworowski EF St-Pierre Y bi-directional induction of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 during T-lymphoma/endothelial cell contact J Immunol 1998, 160(6):2967-2973 9510201
32. Quintanilla-Martinez L Kremer M Keller G Nathrath M Gamboa-Dominguez A Meneses A Luna-Contreras L Cabras A Hoefler H Mohar A Fend F p53 mutations in nasal natural killer/cell lymphoma from Mexico. Association with large cell morphology and advanced disease Am J Pathol 2001, 159:2095-2105 1850589 11733360
33. Folgueras AR Pendas AM Sánchez LM López-Otín C Matriz metalloproteinases in cancer: From new functions to improved inhibition strategies Int J Dev Biol 2004, 48:411-424 10.1387/ ijdb.041811af 15349816